The launch in Thailand marks Wegovy’s entry into the Southeast Asian market. Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm ...

BANGKOK (Reuters) -Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug ...

Read on to learn more about Wegovy, a new obesity medication. Learn how it works, whether it may be right for you and important side effects and warnings.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

Dec. 4, 2024 – People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial. Those who took Zepbound lost on ...

As of May 22, manufacturers are no longer allowed to distribute the compounded versions of semaglutide, which Novo Nordisk sells under the brand Wegovy for weight loss and Ozempic for diabetes.

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey. Originally Published: January 17, 2025 at 10:45 AM CST.

Wegovy is a prescription drug used for long-term weight management. Learn about the side effects it can cause and how to manage them.

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry ...